Nanomedicine News RSS Feed - Nanomedicine

Global Forecast Report on Nanotechnology in Medical Devices Market

Global Forecast Report on Nanotechnology in Medical Devices Market

According to a new market research report "Nanotechnology in Medical Devices Market by Product (Biochip, Implant Materials, Medical Textiles, Wound Dressing, Cardiac Rhythm Management Devices, Hearing Aid), Application (Therapeutic, Diagnostic, Research) - Global Forecast to 2019", published by MarketsandMarkets, the Nanotechnology in Medical Devices Market is was valued at around $5 Billion in 2014 and expected to reach around $8.5 Billion by 2019 with a CAGR of around 11-12% during the forecast period 2014 - 2019. [More]
UTHSC CTRC Begins Nanotherapy Brain Cancer Trial in Humans

UTHSC CTRC Begins Nanotherapy Brain Cancer Trial in Humans

David Williams is the first human being ever to have a new radiation treatment implanted in the center of his brain tumor. [More]
Nanotherapeutics Secures $28.5 Million Debt Financing from White Oak Global Advisors

Nanotherapeutics Secures $28.5 Million Debt Financing from White Oak Global Advisors

Nanotherapeutics, Inc., an integrated biopharmaceutical company with a focus on advanced development and manufacturing, announced today that it has secured a $28.5 million debt financing from White Oak Global Advisors, LLC. The funds will support the completion of the Company’s 180,000 sq. ft. flexible biologics manufacturing facility located in Alachua. [More]
Nanotechnologies in Drug Delivery Congress to be Held 27 - 28 April 2015 in London

Nanotechnologies in Drug Delivery Congress to be Held 27 - 28 April 2015 in London

Diagnosis and Drug Delivery for diseases like cancer, cardiovascular and genetic ailments have always been a concern. In recent years, however, new strides and developments in the Nano-Medicine Market have facilitated more effective diagnosis and drug delivery for diseases. [More]
Immune Licenses Yissum's Patents to Facilitate Development of AmiKet’s Topical Nanoparticle Formulation

Immune Licenses Yissum's Patents to Facilitate Development of AmiKet’s Topical Nanoparticle Formulation

Immune Pharmaceuticals Inc. ("Immune", the "Company") announced today that it has entered into a binding memorandum of understanding with Yissum, the Technology Transfer Company of the Hebrew University of Jerusalem, to license certain of Yissum's patents in order to facilitate the development of a topical nanoparticle formulation of Immune's neuropathic pain drug, AmiKet™. [More]
N1 Technologies Seeks Patent for Nano Engineered TungstenGlass

N1 Technologies Seeks Patent for Nano Engineered TungstenGlass

The directors and management of N1 Technologies Inc. have just filed a Patent for a revolutionary nano engineered super glass called "TungstenGlass." The company has developed a next generation nano based glass that features high impact and torsion resistance along with enhanced electrical properties. [More]
Disposable Molecular Ruler Helps Determine Length of Bacteria’s Nanoscopic Needle

Disposable Molecular Ruler Helps Determine Length of Bacteria’s Nanoscopic Needle

When a salmonella bacterium attacks a cell, it uses a nanoscopic needle to inject it with proteins to aid the infection. If the needle is too short, the cell won’t be infected. Too long, and the needle breaks. Now, University of Utah biologists report how a disposable molecular ruler or tape measure determines the length of the bacterial needle so it is just right. [More]
Nanosphere Uniquely Positioned to Address Critical Healthcare Challenge of CRE Outbreaks

Nanosphere Uniquely Positioned to Address Critical Healthcare Challenge of CRE Outbreaks

Nanosphere, Inc., a company enhancing medicine through targeted molecular diagnostics, offers the Verigene® Gram-Negative Blood Culture Test (BC-GN), approved by the FDA in June 2014 as the first and only FDA-cleared test that rapidly identifies the five carbapenem resistance genes most commonly associated with carbapenem-resistant Enterobacteriaceae (CRE). Three recent outbreaks of CRE, also known as "superbugs," are shining light on the dangers associated with multi-drug-resistant infections. [More]
New Research into Using Magnetic Nanoparticles in Localised Brain Tissue Stimulation

New Research into Using Magnetic Nanoparticles in Localised Brain Tissue Stimulation

MIT researchers have created a technique to stimulate brain tissue using injected magnetic nanoparticles and external magnetic fields. [More]
Light and Targeted Gold Nanoparticles Can Be Used to Activate Non-Genetically Modified Neurons

Light and Targeted Gold Nanoparticles Can Be Used to Activate Non-Genetically Modified Neurons

Light can be used to activate normal, non-genetically modified neurons through the use of targeted gold nanoparticles, report scientists from the University of Chicago and the University of Illinois at Chicago. The new technique, described in the journal Neuron on March 12, represents a significant technological advance with potential advantages over current optogenetic methods, including possible use in the development of therapeutics toward diseases such as macular degeneration. [More]
Site Sponsors
  • Park Systems - Manufacturer of a complete range of AFM solutions
  • Strem Chemicals - Nanomaterials for R&D